{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:49:34Z","timestamp":1789397374746,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s10620-019-05519-4","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T02:47:52Z","timestamp":1550112472000},"page":"2359-2367","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Evidence of Significant Ceftriaxone and Quinolone Resistance in Cirrhotics with Spontaneous Bacterial Peritonitis"],"prefix":"10.1007","volume":"64","author":[{"given":"Eric","family":"Ardolino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilas R.","family":"Patwardhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,14]]},"reference":[{"key":"5519_CR1","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0016-5085(96)70069-0","volume":"111","author":"M Navasa","year":"1996","unstructured":"Navasa M, Follo A, Llovet JM, et al. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology. 1996;111:1011\u20131017.","journal-title":"Gastroenterology"},{"key":"5519_CR2","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/apt.13135","volume":"41","author":"CJ Karvellas","year":"2015","unstructured":"Karvellas CJ, Abraldes JG, Arabi YM, et al. Appropriate and timely antimicrobial therapy in cirrhotic patients with spontaneous bacterial peritonitis-associated septic shock: a retrospective cohort study. Aliment Pharmacol Ther. 2015;41:747.","journal-title":"Aliment Pharmacol Ther"},{"key":"5519_CR3","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/hep.26359","volume":"57","author":"BA Runyon","year":"2013","unstructured":"Runyon BA. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;57:1651\u20131653. https:\/\/doi.org\/10.1002\/hep.26359 .","journal-title":"Hepatology"},{"key":"5519_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/hep.1840050319","volume":"5","author":"J Felisart","year":"1985","unstructured":"Felisart J, Rimola A, Arroyo V, et al. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infection. Hepatology. 1985;5:457\u2013462.","journal-title":"Hepatology"},{"key":"5519_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s005350200006","volume":"37","author":"AV Franca","year":"2002","unstructured":"Franca AV, Giordano HM, Seva-Pereira T, Soares EC. Five days of ceftriaxone to treat spontaneous bacterial peritonitis in cirrhotic patients. J Gastroenterol. 2002;37:119\u2013122.","journal-title":"J Gastroenterol"},{"key":"5519_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/hep.1840210312","volume":"21","author":"A Rimola","year":"1995","unstructured":"Rimola A, Almeron JM, Clemente G, et al. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study. Hepatology. 1995;21:674\u2013679.","journal-title":"Hepatology"},{"key":"5519_CR7","first-page":"455","volume-title":"Gastrointestinal and hepatic infections","author":"JG McHutchison","year":"1995","unstructured":"McHutchison JG, Runyon BA. Spontaneous bacterial peritonitis. In: Surawicz CM, Owen RL, eds. Gastrointestinal and hepatic infections. Philadelphia: WB Saunders; 1995:455."},{"key":"5519_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/hep.1840200107","volume":"20","author":"M Blaise","year":"1994","unstructured":"Blaise M, Paterson D, Trinchet JC, Levacher S, Beaugrand M, Pourriat JL. Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage. Hepatology. 1994;20:34\u201338.","journal-title":"Hepatology"},{"key":"5519_CR9","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/hep.25532","volume":"55","author":"J Fernandez","year":"2012","unstructured":"Fernandez J, Acevedo J, Castro M, et al. Prevalence and risk factors of infections by resistant bacteria in cirrhosis: a prospective study. Hepatology. 2012;55:1551\u20131561.","journal-title":"Hepatology"},{"key":"5519_CR10","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s10620-009-0825-1","volume":"55","author":"T Yakar","year":"2010","unstructured":"Yakar T, Guclu M, Serin E, et al. A recent evaluation of empirical cephalosporin treatment and antibiotic resistance of changing bacterial profiles in spontaneous bacterial peritonitis. Dig Dis Sci. 2010;55:1149\u20131154. https:\/\/doi.org\/10.1007\/s10620-009-0825-1 .","journal-title":"Dig Dis Sci"},{"key":"5519_CR11","doi-asserted-by":"crossref","unstructured":"Sofjan AK, Musgrove RJ, Beyda ND, Russo HP, Lasco TM, et al. Prevalence and predictors of spontaneous bacterial peritonitis due to ceftriaxone-resistant organisms at a large tertiary center in the United States. J Glob Antimicrob Resist. 2018 May 26; PubMed PMID: 29842975.","DOI":"10.1016\/j.jgar.2018.05.015"},{"key":"5519_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/MEG.0000000000001057","volume":"30","author":"M Fiore","year":"2018","unstructured":"Fiore M, Gentile I, Maraolo AE, et al. Are third-generation cephalosporins still the empirical antibiotic treatment of community-acquired spontaneous bacterial peritonitis? A systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2018;30:329\u2013336. https:\/\/doi.org\/10.1097\/MEG.0000000000001057 .","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"5519_CR13","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.3748\/wjg.v23.i25.4654","volume":"23","author":"M Fiore","year":"2017","unstructured":"Fiore M, Maraolo AE, Gentile I, et al. Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: a systematic review. World J Gastroenterol. 2017;23:4654\u20134660. https:\/\/doi.org\/10.3748\/wjg.v23.i25.4654.) .","journal-title":"World J Gastroenterol"},{"key":"5519_CR14","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","volume":"60","author":"R Jalan","year":"2014","unstructured":"Jalan R, Fernandez J, Wiest R, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol. 2014;60:1310\u20131324.","journal-title":"J Hepatol"},{"key":"5519_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1155\/2014\/429536","volume":"28","author":"J Chaulk","year":"2014","unstructured":"Chaulk J, Carbonneau M, Qamar H. Third-generation cephalosporin-resistant spontaneous bacterial peritonitis. Can J Gastroenterol Hepatol. 2014;28:83\u201388.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"5519_CR16","doi-asserted-by":"crossref","unstructured":"Piroth L, Pechinot A, Di Martino V, Hansmann Y, Putot A, et al. Evolving epidemiology and antimicrobial resistance in spontaneous bacterial peritonitis: a two-year observational study. BMC Infect Dis. 2014 May 23;14:287. PubMed PMID: 24884471; PubMed Central PMCID: PMC4055793.","DOI":"10.1186\/1471-2334-14-287"},{"key":"5519_CR17","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.3748\/wjg.v22.i15.4049","volume":"22","author":"A Alexopoulou","year":"2016","unstructured":"Alexopoulou A, Vasilieva L, Agiasotelli D, et al. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia. World J Gastroenterol. 2016;22:4049\u20134056. https:\/\/doi.org\/10.3748\/wjg.v22.i15.4049 .","journal-title":"World J Gastroenterol"},{"key":"5519_CR18","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.4081\/idr.2015.6127","volume":"7","author":"M Falcone","year":"2015","unstructured":"Falcone M, Russo A, Pacini G, et al. Spontaneous bacterial peritonitis due to Methicillin-Resistant Staphylococcus Aureus in a patient with cirrhosis: the potential role for daptomycin and review of the literature. Infect Dis Rep. 2015;7:6127.","journal-title":"Infect Dis Rep"},{"key":"5519_CR19","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/hep.510240617","volume":"24","author":"DJ Hillebrand","year":"1996","unstructured":"Hillebrand DJ, Runyon BA, Yasmineh WG, Rynders GP. Ascitic fluid adenosine deaminase insensitivity in detecting tuberculous peritonitis in the United States. Hepatology. 1996;24:1408.","journal-title":"Hepatology"},{"key":"5519_CR20","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1002\/hep.1840080521","volume":"8","author":"BA Runyon","year":"1988","unstructured":"Runyon BA, Hoefs JC, Morgan TR. Ascitic fluid analysis in malignancy-related ascites. Hepatology. 1988;8:1104.","journal-title":"Hepatology"},{"key":"5519_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0168-8278(90)90140-M","volume":"10","author":"G Pelletier","year":"1990","unstructured":"Pelletier G, Salmon D, Ink O, Hannoun S, Attali P, et al. Culture-negative neutrocytic ascites: a less severe variant of spontaneous bacterial peritonitis. J Hepatol. 1990;10:327\u2013331. PubMed PMID: 2365982.","journal-title":"J Hepatol"},{"key":"5519_CR22","doi-asserted-by":"crossref","unstructured":"Bal CK, Bhatia V, Daman R. Predictors of fifty days in-hospital mortality in patients with culture negative neutrocytic ascites. BMC Gastroenterol. 2017 May 16;17:64. PubMed PMID: 28511674; PubMed Central PMCID: PMC5434542.","DOI":"10.1186\/s12876-017-0621-x"},{"key":"5519_CR23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/00004836-200311000-00011","volume":"37","author":"M Baskol","year":"2003","unstructured":"Baskol M, Gursoy S, Baskol G, et al. Five days of ceftriaxone to treat culture negative neutrocytic ascites in cirrhotic patients. J clin Gastroenterol. 2003;37:403\u2013405.","journal-title":"J clin Gastroenterol"},{"key":"5519_CR24","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1053\/jhep.2003.50119","volume":"37","author":"LT Evans","year":"2003","unstructured":"Evans LT, Kim WR, Poterucha JJ, et al. Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology. 2003;37:897\u2013901.","journal-title":"Hepatology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-019-05519-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05519-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05519-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T21:14:37Z","timestamp":1662930877000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-019-05519-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,14]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["5519"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-05519-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,14]]},"assertion":[{"value":"15 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this type of study, formal consent is not required. This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Waiver for informed consent was approved by the BIDMC IRB committee.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}